Arcutis Biotherapeutics (ARQT)
(Delayed Data from NSDQ)
$8.47 USD
-0.12 (-1.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.45 -0.02 (-0.24%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.65 | 0.00% |
Earnings Summary
For their last quarter, Arcutis Biotherapeutics (ARQT) reported earnings of -$0.72 per share, missing the Zacks Consensus Estimate of -$0.65 per share. This reflects a negative earnings surprise of 10.77%. Look out for ARQT's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.65 per share, reflecting a year-over-year increase of 50.38%.
Earnings History
Price & Consensus
Zacks News for ARQT
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
ARQT: What are Zacks experts saying now?
Zacks Private Portfolio Services